0.10 TWD
−57.02 M TWD
384.41 M TWD
44.06 M
About DABOMB PROTEIN BIOTECH CO
Sector
CEO
Yu Fen Liu
Headquarters
Tainan
Website
Founded
2001
ISIN
TW0006578008
FIGI
BBG00DB2LSF3
Dabomb Protein Biotech Corp. engages in manufacturing and sales of hydrolyzed soya peptide. Its products include hydrolyzed soya peptide, functional peptides, and natural L-lactate. The company was founded by Yu Fen Liu on December 28, 2001 and is headquartered in Tainan, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6578 is 20.00 TWD — it has increased by 3.34% in the past 24 hours. Watch DABOMB PROTEIN BIOTECH CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange DABOMB PROTEIN BIOTECH CO stocks are traded under the ticker 6578.
6578 stock has fallen by −0.50% compared to the previous week, the month change is a 6.63% rise, over the last year DABOMB PROTEIN BIOTECH CO has showed a −4.99% decrease.
6578 reached its all-time high on Jul 20, 2016 with the price of 33.95 TWD, and its all-time low was 12.90 TWD and was reached on Oct 13, 2022. View more price dynamics on 6578 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6578 stock is 1.77% volatile and has beta coefficient of 0.27. Track DABOMB PROTEIN BIOTECH CO stock price on the chart and check out the list of the most volatile stocks — is DABOMB PROTEIN BIOTECH CO there?
Today DABOMB PROTEIN BIOTECH CO has the market capitalization of 1.32 B, it has decreased by −3.47% over the last week.
Yes, you can track DABOMB PROTEIN BIOTECH CO financials in yearly and quarterly reports right on TradingView.
6578 net income for the last quarter is −1.51 M TWD, while the quarter before that showed 5.23 M TWD of net income which accounts for −128.87% change. Track more DABOMB PROTEIN BIOTECH CO financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DABOMB PROTEIN BIOTECH CO EBITDA is 17.25 M TWD, and current EBITDA margin is −2.14%. See more stats in DABOMB PROTEIN BIOTECH CO financial statements.
Like other stocks, 6578 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DABOMB PROTEIN BIOTECH CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DABOMB PROTEIN BIOTECH CO technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DABOMB PROTEIN BIOTECH CO stock shows the sell signal. See more of DABOMB PROTEIN BIOTECH CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.